Lymphoma treatment cost in Austria typically ranges from $2,500 to $5,500 for chemotherapy, while advanced CAR T-cell therapy runs between $350,000 and $500,000. Total expenses depend on the lymphoma subtype, treatment cycles, and whether bone marrow transplantation is required. Patients often find 20-40% savings compared to the US. Most specialized care is concentrated in Vienna.
Typical Lymphoma Treatment Costs in Austria
Bookimed Expert Insight: Patients seeking specialized hematologic oncology benefit from Vienna's university-affiliated clinics. Professor Johannes Drach at Confraternitaet Private Hospital leads a dedicated malignant lymphoma program. For complex cases, Vienna General Hospital (AKH) serves 595,000 patients annually with innovative technologies. Wiener Privatklinik offers individualized cancer treatment with professors from the Medical University of Vienna. These centers provide high-tier safety for both adults and children.
| Turkey | Austria | Spain | |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| Chemotherapy | from $3,000 | from $2,500 | from $2,500 |
| CAR T-cell therapy | from $200,000 | from $350,000 | from $330,000 |
| Bone marrow transplantation | from $27,500 | from $140,000 | from $130,000 |
Univ. Prof. Dr. Wolfgang Köstler is a leading expert in targeted cancer therapies, with over _doctor_1748_years_ of experience in medical oncology.
Professor Drach led the Multiple Myeloma and Malignant Lymphoma program at one of Europe's largest public hospitals – Vienna's General Hospital (AKH).
One of the best cancer specialists in Europe, educator, and cancer researcher, President of the Central European Cooperative Oncology Group (CECOG).
Has published over 600 scientific papers on cancer treatment.
Dr. Arnulf Ferlitsch is a specialist in internal medicine, gastroenterology, and hepatology. He completed his medical studies in Vienna in 1998. He continued his training at top institutions, including UCLA and the University of Pennsylvania. From 2000 to 2010, he focused on internal medicine, gastroenterology, hepatology, and intensive care.
Dr. Ferlitsch has received several research awards, such as the UEGW Best Abstract Award (2003, 2005, 2008, 2009, 2010, 2012), the Ferring Prize, and the Skoda Prize. He founded the hepatic hemodynamics laboratory and the liver cirrhosis outpatient clinic at the Medical University of Vienna. Since 2018, he has led the Department of Internal Medicine I at the Hospital of the Barmherzigen Brüder in Vienna.
Written by Anna Leonova
Written by Halina Shubala